Public statement for collaboration on COVID-19 vaccine development
4.5
$ 16.99
In stock
(769)
Product Description
COVID-19 vaccine challenges: What have we learned so far and what remains to be done? - ScienceDirect
The COVID-19 Vaccine Supply Chain: Potential Problems and Bottlenecks
COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration ― United States, May 11, 2023
Innovative resources help communicate, educate audiences on COVID-19 vaccines: Science-based information can be used with general public, essential workers, health professionals
Africa CDC and Partners mobilize National EPI Managers and other Stakeholders to accelerate COVID-19 vaccination in Africa. – Africa CDC
Fast-forward: Will the speed of COVID-19 vaccine development reset industry norms?
Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic - eClinicalMedicine
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
Covid-19 vaccines production and societal immunization under the serendipity-mindsponge-3D knowledge management theory and conceptual framework
COVID-19 Vaccine Hesitancy: How Did We Get Here and What Do We Do Now?
COVID-19 vaccine development: Collaboration and speed
The journey of a lifetime — development of Pfizer's COVID-19 vaccine - ScienceDirect
Developing Covid-19 Vaccines at Pandemic Speed
Could a single-dose vaccine strategy be more beneficial in COVID-19?
/cdn.vox-cdn.com/uploads/chorus_image/image/58467583/usa_today_10562650.0.jpg)
